Skip Nav Destination
Issues
Molecular Syndromology 2019, Vol. 10, No. 1-2
Title Page / Table of Contents
Mol Syndromol (2019) 10 (1-2): 1–4.
https://doi.org/10.1159/000496411
Preface
Understanding Craniosynostosis: Clinical Practice to Basic Science
Mol Syndromol (2019) 10 (1-2): 5.
https://doi.org/10.1159/000492958
Review Article
Genetic Causes of Craniosynostosis: An Update
Mol Syndromol (2019) 10 (1-2): 6–23.
https://doi.org/10.1159/000492266
Structural Genome Variations Related to Craniosynostosis
Mol Syndromol (2019) 10 (1-2): 24–39.
https://doi.org/10.1159/000490480
Original Article
Craniofrontonasal Syndrome Caused by Introduction of a Novel uATG in the 5′UTR of EFNB1
Vanessa L. Romanelli Tavares; Erika Kague; Camila M. Musso; Thiago G.P. Alegria; Renato S. Freitas; Debora R. Bertola; Stephen R.F. Twigg; Maria R. Passos-Bueno
Mol Syndromol (2019) 10 (1-2): 40–47.
https://doi.org/10.1159/000490635
The Osteogenic Potential of the Neural Crest Lineage May Contribute to Craniosynostosis
Mol Syndromol (2019) 10 (1-2): 48–57.
https://doi.org/10.1159/000493106
Review Article
Mouse Models of Syndromic Craniosynostosis
Mol Syndromol (2019) 10 (1-2): 58–73.
https://doi.org/10.1159/000491004
An Overview of Modelling Craniosynostosis Using the Finite Element Method
Mol Syndromol (2019) 10 (1-2): 74–82.
https://doi.org/10.1159/000490833
Syndromic Craniosynostosis: Complexities of Clinical Care
Justine O''Hara; Federica Ruggiero; Louise Wilson; Greg James; Graeme Glass; Owase Jeelani; Juling Ong; Richard Bowman; Michelle Wyatt; Robert Evans; Martin Samuels; Richard Hayward; David J. Dunaway
Mol Syndromol (2019) 10 (1-2): 83–97.
https://doi.org/10.1159/000495739
Original Article
An FDA-Approved Drug Screen for Compounds Influencing Craniofacial Skeletal Development and Craniosynostosis
Marian Seda; Maartje Geerlings; Peggy Lim; Jeshmi Jeyabalan-Srikaran; Ann-Christin Cichon; Peter J. Scambler; Philip L. Beales; Victor Hernandez-Hernandez; Andrew W. Stoker; Dagan Jenkins
Mol Syndromol (2019) 10 (1-2): 98–114.
https://doi.org/10.1159/000491567
Review Article
Current Approaches in the Development of Molecular and Pharmacological Therapies in Craniosynostosis Utilizing Animal Models
Mol Syndromol (2019) 10 (1-2): 115–123.
https://doi.org/10.1159/000493535
